{"product_id":"test-urinaire-cassette-11-drogues","title":"11-Drug Urine Test Drugdiag® 11","description":"\u003cstyle\u003e\n\/* =========================================================\n   AMA Prévention — B-SAFE\n   Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n   Sans JS — prêt Shopify\n   ========================================================= *\/\n\n.ama-bsafe-2026 {\n  --ama-blue: #004C96;\n  --ama-blue-deep: #003B78;\n  --ama-blue-night: #00325f;\n  --ama-orange: #FE4B09;\n  --ama-text: #004C96;\n  --ama-muted: #667085;\n  --ama-border: #dbe6f2;\n  --ama-soft: #f6f9fd;\n  --ama-white: #ffffff;\n\n  width: 100%;\n  max-width: 1180px;\n  margin: 0 auto;\n  padding: 0;\n  font-family: inherit;\n  color: var(--ama-text);\n  background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n  box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n  min-width: 0;\n}\n\n.ama-bsafe-panel {\n  width: 100%;\n  position: relative;\n  overflow: hidden;\n  isolation: isolate;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 28px;\n  background:\n    radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n    radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n    linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n  box-shadow:\n    0 22px 55px rgba(0, 76, 150, 0.10),\n    inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n  width: 100%;\n  padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n  margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  margin-bottom: 14px;\n  padding: 7px 12px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 12px;\n  font-weight: 900;\n  letter-spacing: 0.04em;\n  text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n  margin: 0 0 16px;\n  color: var(--ama-blue);\n  font-size: clamp(30px, 4vw, 46px);\n  line-height: 1.08;\n  font-weight: 900;\n  letter-spacing: -0.045em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n  margin: 0 0 16px;\n  color: var(--ama-text);\n  font-size: clamp(16px, 1.4vw, 18px);\n  line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n  color: var(--ama-blue);\n  font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n  display: flex;\n  flex-wrap: wrap;\n  gap: 10px;\n  margin-top: 26px;\n  padding: 14px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: rgba(255, 255, 255, 0.72);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  flex: 1 1 230px;\n  padding: 10px 12px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  color: var(--ama-blue);\n  font-size: 14px;\n  font-weight: 850;\n  line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n  flex-shrink: 0;\n}\n\n\/* =========================================================\n   Accordéon principal\n   Fermé : bleu nuit\n   Ouvert : clair + contenu dans le même bloc\n   ========================================================= *\/\n\n.ama-bsafe-accordion {\n  width: 100%;\n  max-width: 920px;\n  margin: 0 auto;\n  display: grid;\n  gap: 12px;\n}\n\n.ama-bsafe-item {\n  border-radius: 24px;\n  overflow: hidden;\n  background:\n    linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n  border: 1px solid rgba(0, 76, 150, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.22),\n    inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n    0 16px 36px rgba(0, 76, 150, 0.17);\n  transition:\n    background 220ms ease,\n    box-shadow 220ms ease,\n    border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n  background:\n    radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n    linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n  border-color: rgba(0, 76, 150, 0.14);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.98),\n    0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n  position: relative;\n  min-height: 66px;\n  padding: 14px 58px 14px 18px;\n  display: flex;\n  align-items: center;\n  cursor: pointer;\n  list-style: none;\n  user-select: none;\n  -webkit-tap-highlight-color: transparent;\n  color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-item[open] summary {\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n  border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 16px;\n  top: 50%;\n  width: 36px;\n  height: 36px;\n  transform: translateY(-50%);\n  border-radius: 999px;\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  color: #ffffff;\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n  border: 1px solid rgba(255, 255, 255, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.30),\n    0 10px 22px rgba(0, 0, 0, 0.14);\n  font-size: 22px;\n  font-weight: 760;\n  line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n  content: \"−\";\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n  border-color: rgba(0, 76, 150, 0.10);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.96),\n    0 8px 18px rgba(0, 76, 150, 0.10);\n  font-size: 24px;\n  font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-item:not([open]):hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.26),\n      inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n      0 20px 44px rgba(0, 76, 150, 0.22);\n  }\n\n  .ama-bsafe-item[open]:hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.98),\n      0 18px 42px rgba(0, 76, 150, 0.13);\n  }\n}\n\n.ama-bsafe-acc-title {\n  display: block;\n  font-size: 16px;\n  line-height: 1.18;\n  font-weight: 800;\n  letter-spacing: -0.018em;\n  color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n  display: block;\n  margin-top: 3px;\n  font-size: 13px;\n  line-height: 1.24;\n  font-weight: 650;\n  letter-spacing: -0.01em;\n  color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n  color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n  padding: clamp(20px, 4vw, 34px);\n  background: transparent;\n  animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n  from {\n    opacity: 0;\n    transform: translateY(5px);\n  }\n\n  to {\n    opacity: 1;\n    transform: translateY(0);\n  }\n}\n\n\/* =========================================================\n   Contenu\n   ========================================================= *\/\n\n.ama-bsafe-content h2 {\n  margin: 0 0 18px;\n  color: var(--ama-blue);\n  font-size: clamp(24px, 3vw, 36px);\n  line-height: 1.10;\n  font-weight: 900;\n  letter-spacing: -0.04em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n  content: \"\";\n  display: block;\n  width: 78px;\n  height: 4px;\n  margin-top: 14px;\n  border-radius: 999px;\n  background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n  margin: 0 0 10px;\n  color: var(--ama-blue);\n  font-size: clamp(18px, 1.7vw, 23px);\n  line-height: 1.18;\n  font-weight: 900;\n  letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n  margin: 0 0 18px;\n  color: var(--ama-text);\n  font-size: 16px;\n  line-height: 1.72;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n  display: grid;\n  grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n  gap: 18px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-card {\n  position: relative;\n  min-height: 150px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 22px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow-wrap: break-word;\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n  margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-card:hover,\n  .ama-bsafe-substance-row:hover {\n    transform: translateY(-2px);\n    border-color: rgba(254, 75, 9, 0.32);\n    background: #ffffff;\n    box-shadow:\n      0 16px 34px rgba(0, 76, 150, 0.10),\n      inset 0 1px 0 rgba(255, 255, 255, 0.95);\n  }\n}\n\n.ama-bsafe-substance-list {\n  display: grid;\n  gap: 12px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n  width: 100%;\n  display: flex;\n  align-items: center;\n  flex-wrap: wrap;\n  gap: 12px 18px;\n  padding: 16px 18px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 130px;\n  width: 130px;\n  min-width: 130px;\n  max-width: 130px;\n  min-height: 38px;\n  padding: 7px 14px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 15px;\n  font-weight: 950;\n  letter-spacing: -0.01em;\n  text-align: center;\n}\n\n.ama-bsafe-substance-main {\n  flex: 1 1 420px;\n  min-width: min(100%, 320px);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 auto;\n  margin-left: auto;\n  min-height: 34px;\n  padding: 6px 12px;\n  border-radius: 999px;\n  background: rgba(254, 75, 9, 0.08);\n  color: var(--ama-orange);\n  font-size: 13px;\n  font-weight: 900;\n  white-space: nowrap;\n}\n\n.ama-bsafe-list {\n  list-style: none;\n  padding: 0;\n  margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n  position: relative;\n  padding: 15px 18px 15px 44px;\n  margin-bottom: 10px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.84);\n  box-shadow:\n    0 6px 18px rgba(0, 76, 150, 0.035),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.62;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n  content: \"\";\n  position: absolute;\n  left: 18px;\n  top: 22px;\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n  margin: 22px 0;\n  padding: 18px 20px;\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  border-radius: 18px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  color: var(--ama-muted);\n  font-size: 14px;\n  line-height: 1.62;\n  font-style: italic;\n  box-shadow:\n    0 8px 20px rgba(0, 76, 150, 0.04),\n    inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n  margin: 28px 0;\n  padding: 24px;\n  border-radius: 22px;\n  background:\n    radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n    linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  box-shadow:\n    0 16px 34px rgba(254, 75, 9, 0.22),\n    inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n  color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n  margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n  margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n  display: grid;\n  gap: 12px;\n  margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n  cursor: pointer;\n  padding: 18px 50px 18px 18px;\n  color: var(--ama-blue);\n  font-weight: 900;\n  line-height: 1.35;\n  list-style: none;\n  position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-faq summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 18px;\n  top: 50%;\n  transform: translateY(-50%);\n  color: var(--ama-orange);\n  font-size: 24px;\n  line-height: 1;\n  font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n  content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n  padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n  margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n  margin-top: 30px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 24px;\n  background:\n    radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n    linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 14px 34px rgba(0, 76, 150, 0.08),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n  margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  min-height: 46px;\n  padding: 12px 22px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  color: #ffffff !important;\n  font-weight: 900;\n  text-decoration: none;\n  box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n  margin-top: 30px;\n  padding-top: 22px;\n  border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n  margin: 0;\n  color: var(--ama-muted);\n  font-size: 13px;\n  line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n  max-width: 1180px;\n  margin: 32px auto 0;\n  padding: 24px;\n  border: 1px solid rgba(0, 76, 150, 0.18);\n  border-radius: 22px;\n  background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n  box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n  color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n  margin: 0 0 8px;\n  font-size: 13px;\n  letter-spacing: 0.08em;\n  text-transform: uppercase;\n  font-weight: 900;\n  color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n  margin: 0 0 12px;\n  color: #004c96;\n  font-size: clamp(22px, 2.4vw, 30px);\n  line-height: 1.15;\n  font-weight: 900;\n  letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n  margin: 0 0 10px;\n  line-height: 1.65;\n  color: #184b78;\n  font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n  margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n  .ama-bsafe-grid {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n  }\n\n  .ama-bsafe-substance-row {\n    display: grid;\n    grid-template-columns: 130px minmax(0, 1fr);\n    align-items: start;\n    gap: 10px 14px;\n  }\n\n  .ama-bsafe-substance-code {\n    grid-column: 1;\n    grid-row: 1;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 2;\n    grid-row: 1;\n    justify-self: start;\n    margin-left: 0;\n  }\n\n  .ama-bsafe-substance-main {\n    grid-column: 1 \/ -1;\n    grid-row: 2;\n    min-width: 0;\n    width: 100%;\n  }\n}\n\n@media (max-width: 640px) {\n  .ama-bsafe-panel {\n    border-radius: 22px;\n  }\n\n  .ama-bsafe-inner {\n    padding: 24px 14px;\n  }\n\n  .ama-bsafe-title {\n    font-size: clamp(28px, 8.4vw, 36px);\n    letter-spacing: -0.035em;\n  }\n\n  .ama-bsafe-summary-strip {\n    display: grid;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-summary-item {\n    border-radius: 16px;\n  }\n\n  .ama-bsafe-accordion {\n    gap: 10px;\n  }\n\n  .ama-bsafe-item {\n    border-radius: 20px;\n  }\n\n  .ama-bsafe-item summary {\n    min-height: 60px;\n    padding: 12px 52px 12px 15px;\n  }\n\n  .ama-bsafe-item summary::after {\n    right: 14px;\n    width: 32px;\n    height: 32px;\n    font-size: 20px;\n  }\n\n  .ama-bsafe-item[open] summary::after {\n    font-size: 22px;\n  }\n\n  .ama-bsafe-acc-title {\n    font-size: 15px;\n    line-height: 1.18;\n    letter-spacing: -0.014em;\n  }\n\n  .ama-bsafe-acc-sub {\n    font-size: 12.2px;\n    line-height: 1.22;\n  }\n\n  .ama-bsafe-content {\n    padding: 20px 15px;\n  }\n\n  .ama-bsafe-content h2 {\n    font-size: clamp(24px, 7vw, 30px);\n  }\n\n  .ama-bsafe-grid {\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-card {\n    padding: 20px;\n  }\n\n  .ama-bsafe-substance-row {\n    padding: 16px;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-substance-code {\n    width: fit-content;\n    min-width: 0;\n    max-width: 100%;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 1;\n    grid-row: auto;\n  }\n\n  .ama-bsafe-validation {\n    padding: 20px;\n    border-radius: 20px;\n  }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 11 urinaire\"\u003e\n  \u003cdiv class=\"ama-bsafe-panel\"\u003e\n    \u003cdiv class=\"ama-bsafe-inner\"\u003e\n      \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003e11-drug urine test\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® 11: broad-spectrum multi-drug urine test \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e The \u003cstrong\u003eDrugdiag® 11 drugs urine test\u003c\/strong\u003e, developed by the French laboratory \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, the leader in rapid diagnostic tests, allows \u003cstrong\u003esimultaneous detection of 11 drug families\u003c\/strong\u003e in urine. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e It notably detects \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eamphetamines\u003c\/strong\u003e, \u003cstrong\u003ebarbiturates\u003c\/strong\u003e, \u003cstrong\u003ebenzodiazepines\u003c\/strong\u003e, \u003cstrong\u003ebuprenorphine\u003c\/strong\u003e, \u003cstrong\u003ecocaine\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003emethamphetamines\u003c\/strong\u003e, \u003cstrong\u003eopiates\u003c\/strong\u003e, \u003cstrong\u003emethadone\u003c\/strong\u003e, and \u003cstrong\u003etricyclic antidepressants\u003c\/strong\u003e. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e This multi-drug test is particularly suited for \u003cstrong\u003ebusinesses\u003c\/strong\u003e, \u003cstrong\u003eoccupational physicians\u003c\/strong\u003e, \u003cstrong\u003eaddiction treatment centers\u003c\/strong\u003e, \u003cstrong\u003ehealth professionals\u003c\/strong\u003e, and organizations that need to secure environments with high levels of responsibility. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eSimultaneous detection of 11 families\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eRapid-read urine format\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUse in business, health, and addiction treatment\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n      \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eDetection\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003e11 targeted families\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eDetected substances\u003c\/h2\u003e \u003cp\u003e The Drugdiag® 11 urine test allows broad screening of the main families of psychoactive substances, including both the most common narcotics, certain psychoactive medications, and molecules used in addiction monitoring. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e main metabolite of THC, associated with consumption of cannabis, resin, flowers, or products containing THC.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e amphetamine-type stimulants, speed, and related substances.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbiturates:\u003c\/strong\u003e family of central nervous system depressants.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepines:\u003c\/strong\u003e anxiolytics, hypnotics, or sedatives that can impair alertness.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorphine:\u003c\/strong\u003e molecule used notably in some opioid substitution treatments.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaine:\u003c\/strong\u003e cocaine, crack, and related metabolites detectable in urine.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA and related substances.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e crystal meth, ice, and related derivatives.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e morphine, heroin, opium, and related compounds.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethadone:\u003c\/strong\u003e molecule used notably in some opioid substitution treatments.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eTricyclic antidepressants:\u003c\/strong\u003e family of psychoactive drugs sought in certain clinical contexts.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Thresholds must be interpreted according to the manufacturer’s instructions, clinical or professional context, and screening objectives. In case of a positive result, laboratory confirmation may be necessary depending on the context. \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eUses\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eBusiness, health, safety\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eMain uses\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eSensitive positions and high-risk sectors\u003c\/h3\u003e \u003cp\u003e The Drugdiag® 11 is particularly suited for security and safety positions: transport, logistics, construction, heavy industry, maintenance of sensitive installations, energy, classified sites, or high-responsibility environments. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTherapeutic monitoring and addiction medicine\u003c\/h3\u003e \u003cp\u003e Thanks to the detection of \u003cstrong\u003emethadone\u003c\/strong\u003e, \u003cstrong\u003ebuprenorphine\u003c\/strong\u003e, and \u003cstrong\u003eTCA\u003c\/strong\u003e, this test can be useful for CSAPA, doctors, psychiatrists, clinics, and detox centers to document follow-up, complementing clinical interviews. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eWorkplace prevention\u003c\/h3\u003e \u003cp\u003e When provided for in internal regulations, this test can be integrated into an internal prevention procedure: targeted control, risk situation, accident, incident, or overall safety approach. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eResponsible self-monitoring\u003c\/h3\u003e \u003cp\u003e The Drugdiag® 11 can also be used by individuals for self-monitoring before a medical appointment, professional visit, or administrative procedure. Laboratory confirmation remains necessary in any official context. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eAdvantages of the Drugdiag® 11 test\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eExtended detection:\u003c\/strong\u003e 11 substance families detected in a single analysis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eVersatile tool:\u003c\/strong\u003e companies, occupational health, addiction medicine, medico-social structures, institutions, and self-monitoring.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQuick reading:\u003c\/strong\u003e visual result in minutes according to the manufacturer’s instructions.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFrench manufacturer:\u003c\/strong\u003e device from the Drugdiag® range by Toda Pharma laboratory.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eProfessional quality:\u003c\/strong\u003e CE marking, ISO 13485 quality environment, and batch traceability.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eAddiction monitoring:\u003c\/strong\u003e BUP, MTD, and TCA panels useful in certain medical contexts.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePrevention policy:\u003c\/strong\u003e integrable into a comprehensive approach of information, training, and support.\u003c\/li\u003e \u003c\/ul\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eRegulated use in companies\u003c\/h3\u003e \u003cp\u003e In the workplace, the use of screening tests must be provided for in the internal regulations, justified by the nature of the tasks, and implemented in compliance with the Labor Code, employee rights, and confidentiality. \u003c\/p\u003e \u003cp\u003e The Drugdiag® 11 test is part of a comprehensive prevention policy and never replaces clinical evaluation or confirmatory laboratory analyses when required. \u003c\/p\u003e \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eResults\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eUrine durations\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eUrine detection times\u003c\/h2\u003e \u003cp\u003e The detection time of substances in urine depends on many factors: frequency of use, quantity, metabolism, health status, kidney function, hydration, ongoing treatment, and length of use. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e indicative duration highly variable depending on frequency and intensity of use.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 30 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbiturates:\u003c\/strong\u003e indicative duration varies depending on the molecule, dose, and usage.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 5 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepines:\u003c\/strong\u003e indicative duration varies and can be longer with prolonged treatment.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7+ days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorphine:\u003c\/strong\u003e indicative duration varies depending on dose, frequency, and treatment duration.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaine:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e indicative duration generally between 1 and 3 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 3 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethadone:\u003c\/strong\u003e indicative duration varies depending on the therapeutic regimen.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eTricyclic antidepressants:\u003c\/strong\u003e indicative duration varies depending on the molecule and dosage.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e These detection windows are indicative and can never serve as absolute proof of consumption or abstinence. They must be interpreted according to the clinical context, the person’s statements, and, if necessary, additional examinations. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eNegative result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A negative result indicates that the targeted drug families were not detected above the test thresholds. This does not guarantee the absolute absence of any substance. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003ePositive result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A positive result indicates a reaction compatible with the presence of one or more targeted drug families in the urine. Laboratory confirmation is recommended in any official, medical, disciplinary, or disputed context. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eInvalid result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e An invalid result may be due to incorrect handling, insufficient sample volume, or failure to respect the reading time. In this case, the test should be repeated with a new device. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eTechnique\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQuality and reliability\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eTechnical expertise\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eColloidal gold technology\u003c\/h3\u003e \u003cp\u003e The device uses competitive immunochromatography with colloidal gold-labeled antibodies, allowing clear, rapid reading suitable for professional use. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eGC\/MS reliability\u003c\/h3\u003e \u003cp\u003e The accuracy of this professional urine screening device has been compared to the laboratory reference method, gas chromatography coupled with mass spectrometry (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e). \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eQuality compliance\u003c\/h3\u003e \u003cp\u003e Designed by the French laboratory Toda Pharma, this \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is CE marked, complies with the \u003cstrong\u003eISO 13485\u003c\/strong\u003e quality standard, and offers full batch traceability. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eMain features\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTest type:\u003c\/strong\u003e rapid-read multi-drug urine test.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstances tested:\u003c\/strong\u003e THC-COOH, AMP, BAR, BZO, BUP, COC, MDMA, MET, MOP, MTD, TCA.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e easy-to-use urine test with visual reading of result strips.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUse:\u003c\/strong\u003e professional prevention, occupational medicine, addiction treatment, therapeutic monitoring, self-monitoring.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e French laboratory Toda Pharma, the number 1 in rapid diagnostic testing.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQuality:\u003c\/strong\u003e in vitro diagnostic medical device with CE marking and ISO 13485 certification.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eNo cross-reactivity\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eCommon medications:\u003c\/strong\u003e aspirin, ibuprofen, paracetamol, amoxicillin, penicillin, dextromethorphan.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePhysiological and dietary substances:\u003c\/strong\u003e caffeine, cholesterol, hemoglobin, creatinine, vitamin C, uric acid.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e The test must be used according to the manufacturer's instructions. In case of a positive, doubtful, or disputed result, confirmation by laboratory analysis is still recommended. \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eFAQ\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFrequently Asked Questions\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eWhat does the Drugdiag® 11 urine test detect?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e It detects 11 families of substances in urine: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eBAR\u003c\/strong\u003e, \u003cstrong\u003eBZO\u003c\/strong\u003e, \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMOP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e, and \u003cstrong\u003eTCA\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eWho is this test for?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e It is intended for companies, occupational physicians, addiction centers, healthcare professionals, organizations exposed to security risks, and individuals wishing to perform responsible self-monitoring. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eIs this test suitable for addiction monitoring?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Yes. The \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e, and \u003cstrong\u003eTCA\u003c\/strong\u003e panels, combined with other targeted families, can be useful in certain therapeutic or addiction follow-ups, complementing clinical evaluation. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eCan it be used in the workplace?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Yes, if its use is provided for by internal regulations, justified by the nature of the tasks, proportionate to the risk, and implemented in compliance with the Labor Code, employee rights, and confidentiality. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eDoes a positive result have definitive value?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e No. A rapid test provides a preliminary analytical result. In any official, judicial, administrative, disciplinary, medical, or disputed context, confirmation by laboratory analytical method is recommended. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003eNeed advice or a quote for a professional order?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Request a quote \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eLegal notice:\u003c\/strong\u003e This \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is intended for professional use and, where applicable, responsible personal use, in compliance with current French and European legislation. It provides a preliminary analytical result and does not replace a confirmatory laboratory analysis within the framework of judicial, administrative, medical, disciplinary, or disputed procedures. \u003c\/p\u003e \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unit","offer_id":56426434199876,"sku":"10411","price":19.0,"currency_code":"USD","in_stock":true},{"title":"Pack of 5","offer_id":56426434232644,"sku":"10411","price":95.0,"currency_code":"USD","in_stock":true},{"title":"Pack of 10","offer_id":56426434265412,"sku":"10411","price":179.0,"currency_code":"USD","in_stock":true},{"title":"Pack of 25","offer_id":56426434298180,"sku":"10411","price":400.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_Poduit_du_drugdiag_11.png?v=1777888364","url":"https:\/\/ama-prevention.com\/products\/urine-test-cassette-11-drugs","provider":"AMA Prévention ","version":"1.0","type":"link"}